Paul Tudor Jones Medical Devices

Tudor Investment Corp Et Al

  • $26.8 Billion
  • Q3 2024

Stock List

Stock Option Type Value Options Held Last Trade Trade History
ALGN
Align Technology Inc
CALL
$10.8 Million
42.5K
Q1 2024
Added 162.71%
ALGN
Align Technology Inc
PUT
$6.69 Million
26.3K
Q1 2024
Added 162.71%
ABT
Abbott Laboratories
CALL
$5.14 Million
45.1K
Q3 2024
Reduced 43.12%
MDT
Medtronic PLC
CALL
$5.01 Million
55.6K
Q2 2024
Added 4884.67%
SYK
Stryker Corp
PUT
$2.28 Million
6.3K
Q3 2024
New holding
MDT
Medtronic PLC
PUT
$1.85 Million
20.5K
Q2 2024
Added 4884.67%
SYK
Stryker Corp
CALL
$1.01 Million
2.8K
Q3 2024
New holding
TMDX
Trans Medics Group, Inc.
PUT
$894,000
5.7K
Q2 2024
Added 67.43%
PEN
Penumbra Inc
CALL
$582,000
3K
Q2 2023
New holding
BSX
Boston Scientific Corp
CALL
$578,000
6.9K
Q3 2024
Added 2169.19%
ABT
Abbott Laboratories
PUT
$467,000
4.1K
Q3 2024
Reduced 43.12%
TMDX
Trans Medics Group, Inc.
CALL
$408,000
2.6K
Q2 2024
Added 67.43%
INMD
In Mode Ltd.
PUT
$243,000
14.4K
Q1 2023
Added 111.58%
Filter Shares Options
Paul Tudor Jones

Paul Tudor Jones

Paul Tudor Jones is the founder and CEO of Tudor Investment Corp, a successful investment firm that focuses on macro investing. Jones is known for his expertise in macro investing and his innovative approach to investing. He has generated strong returns for his clients over the long term.
Track Paul Tudor Jones's portfolio
Track Paul Tudor Jones's Portfolio

Track Paul Tudor Jones Portfolio

Follow Paul Tudor Jones (Tudor Investment Corp Et Al) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email